Via current research, we have noted the remarkable up-regulation of MTHFD1L in BLCA, HNSC, KIRP, LUAD, and UCEC patients of different clinicopathological features (different cancer stages, patients races, genders, and age groups). This evidence concerns the gene MTHFD1L and cancer.